About 29% of acinar PCs, 7% of ductal PCs, and 46% of neuroendocrine carcinomas/tumors were immunohistochemically positive for PD-L1 (further details are available in the other parts of our review). This evidence concerns the gene CD274 and neuroendocrine carcinoma.